SCHEMBL16242571

SCHEMBL16242571

Oc1ccc(Cc2ccccc2)cc1.Oc1ccccc1Cc1ccccc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.88
ALOX5 P09917 2/20 0.63
HSPA5 P11021 1/20 0.58
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
BCL2 P10415 1/20 0.55
BCL2L1 Q07817 1/20 0.55
IDH1 O75874 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CALM1 P0DP23 1/20 0.48
PKM P14618 1/20 0.47
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL920838 0.96 KEAP1 (0.96) KEAP1ALOX5HSPA5ESR1ESR2
SCHEMBL68653 0.94 KEAP1 (1.00) KEAP1ALOX5HSPA5ESR1ESR2
SCHEMBL29506902 0.94 KEAP1 (1.00) KEAP1ALOX5HSPA5ESR1ESR2
SCHEMBL12589848 0.90 KEAP1 (0.85) KEAP1ALOX5HSPA5ESR1ESR2
SCHEMBL8519994 0.90 ALOX5 (0.77) KEAP1ALOX5HSPA5ESR1ESR2
SCHEMBL30335116 0.89 KEAP1 (0.75) KEAP1ALOX5HSPA5BCL2BCL2L1
SCHEMBL87816 0.89 KEAP1 (0.75) KEAP1ALOX5HSPA5BCL2BCL2L1
SCHEMBL28998999 0.87 KEAP1 (0.72) KEAP1ALOX5HSPA5BCL2BCL2L1
SCHEMBL27940839 0.87 KEAP1 (0.72) KEAP1ALOX5HSPA5BCL2BCL2L1
SCHEMBL27940823 0.87 KEAP1 (0.72) KEAP1ALOX5HSPA5BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504248-B2 Antimicrobial composition ROHM AND HAAS COMPANY (US) 2016-11-29 US disclosed
US-20140350121-A1 ANTIMICROBIAL COMPOSITION DOW GLOBAL TECHNOLOGIES LLC 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350121-A1 ANTIMICROBIAL COMPOSITION TAS2R40, TAS2R39, POLR1C KEAP1 3237/4885ALOX5 1052/4885HSPA5 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.